Markus Hirshman
Epilepsy, a neurological disorder characterized by recurrent seizures, affects approximately 50 million people worldwide. Historically, the management of epilepsy has relied on a one-size-fits-all approach, with antiepileptic drugs (AEDs) prescribed based on general seizure type and broad patient characteristics. However, recent advancements in personalized medicine are revolutionizing this paradigm by tailoring treatments to individual genotypes, offering the promise of more effective and precise management for patients. Antiepileptic Drugs (AEDs), also known as anticonvulsants, are medications used to manage and prevent seizures in individuals with epilepsy. Epilepsy is a neurological disorder characterized by recurrent seizures, which can vary widely in type and severity. AEDs aim to control these seizures, improve the quality of life and reduce the frequency and intensity of epileptic episodes.
இந்தக் கட்டுரையைப் பகிரவும்
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 